A single drug, study failures leave Anavex with nothing but cash

MollyFerguson/STATIttookAnavexLifeSciencessevenmonthstofinallyacknowledgethefailureofalate-stageclin ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean




fashion

author：focus    Page View：83
Drug cost scale
Adobe

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

advertisement

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： JPM: CVS says Medicare Advantage patients are impacting profits
Next article： At least 13 dead in Texas as scorching temps continue